DHT is a potent agonist of the AR, and is in fact the most potent known endogenous ligand of the receptor. It has an affinity (K d ) of to nM for the human AR, which is about 2- to 3-fold higher than that of testosterone (K d = to nM)  and 15–30 times higher than that of adrenal androgens .  In addition, the dissociation rate of DHT from the AR is 5-fold slower than that of testosterone.  The EC 50 of DHT for activation of the AR is nM, which is about 5-fold stronger than that of testosterone (EC 50 = nM).  In bioassays , DHT has been found to be - to 10-fold more potent than testosterone. 
Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.